Correlations among quantitative assays that measure the size of HIV reservoirs in people with HIV receiving antiretroviral therapy

Affiliations

¹ Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases.
² Critical Care Medicine Department, Clinical Center, NIH, Bethesda, Maryland.
³ Departments of Chemistry and Chemical and Systems Biology, Stanford University, California, USA.

Adeline B Sewack et al. AIDS. 2025.

. 2025 Nov 1;39(13):1982-1984.

doi: 10.1097/QAD.0000000000004297. Epub 2025 Sep 25.

¹ Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases.
² Critical Care Medicine Department, Clinical Center, NIH, Bethesda, Maryland.
³ Departments of Chemistry and Chemical and Systems Biology, Stanford University, California, USA.

No abstract available

References

1. Trickey A, Sabin CA, Burkholder G, Crane H, d’Arminio Monforte A, Egger M, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV 2023; 10:e295–e307.
1. Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 1997; 94:13193–13197.
1. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278:1295–1300.
1. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997; 278:1291–1295.
1. Chun TW, Moir S, Fauci AS. HIV reservoirs as obstacles and opportunities for an HIV cure. Nat Immunol 2015; 16:584–589.